Clinical and laboratory characteristics of acute myeloid leukaemia (AML) at relapse and the risk of acute incapacitation.
Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Michael
M
Spencer Chapman
Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Shamzah
S
Araf
Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
Matthew
M
Smith
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006304:Health Status; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012008:Recurrence; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
CANCER; HAEM-ONCOLOGY; LEUKAEMIA; MANAGEMENT; ONCOGENES